Helmsley’s Type 1 Diabetes program awards grants to projects that work toward better understanding of the disease, development of innovative treatments, and improvement of care and access. The overall goal of its grantmaking, according to Helmsley is to “improve health outcomes,” for people suffering Type 1 diabetes, and “strengthen the effort to someday eradicate this disease.” The trust’s IBD and Crohn’s Disease program focuses its grantmaking efforts on finding a cure for IBD as well as discovering better therapies and prevention strategies. Helsmley also supports Basic Medical Research and the development of Biomedical Research Infrastructure.

The Helmsley Trust’s grants are substantial and typically range from around $150,000 to upwards of $4 million. Helmsley tends to favor large medical centers, hospitals and leading research institutions in its grantmaking. Helmsley’s grants database offers a closer look at the types of organization it funds.

On rare occasions, the Helmsley Trust will announce a Request for Proposals. Otherwise, it only funds organizations it identifies on its own and does not accept unsolicited grant requests.